pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
209
stories
Jun 12, 26
Chile offers new data on food warning label efficacy
stat
Jun 12, 26
Opinion: Ebola outbreak response requires engaging with religious traditions and leaders
stat
Jun 11, 26
Drinking during pregnancy rose after 2020, new CDC data suggest
stat
Jun 11, 26
Study highlights influence of socioeconomic status on children’s brain development
stat
Jun 11, 26
Summit pulls $500M share sale a day after announcing it
biopharma dive
Jun 11, 26
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
biopharma dive
Jun 11, 26
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
biopharma dive
Jun 11, 26
Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850
stat
Jun 10, 26
Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust
stat
Jun 10, 26
Ethyreal starts up with $101M and takes aim at a pair of immune diseases
biopharma dive
Jun 9, 26
Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
stat
Jun 9, 26
A leader of the 2014 U.S. Ebola response compares then to now
stat
Jun 8, 26
City banks nearly $100M for next-gen RNAi drugs
biopharma dive
Jun 8, 26
#ADA26: Novo Nordisk targets 2030 launch for triple-G obesity shot
endpoints
Jun 8, 26
When it’s time to save a limb, novel clinic meets unhoused people where they are
stat
Jun 7, 26
STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA
stat
Jun 6, 26
STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending
stat
Jun 6, 26
#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this year
endpoints
Jun 6, 26
Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous action
stat
Jun 5, 26
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
stat
Jun 5, 26
Senior NIH official pushes MAHA strategy to skeptical ADA audience
stat
Jun 5, 26
Study data convince Lundbeck to push new migraine drug forward
biopharma dive
Jun 4, 26
Alnylam, Inceptive ink AI deal potentially worth $2B
biopharma dive
Jun 4, 26
Male puberty is understudied — but when it starts may predict long-term health risks
stat
Jun 3, 26
Opinion: The medical-billing AI arms race between providers and insurance
stat
Jun 2, 26
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
biopharma dive
Jun 2, 26
How one state’s medical meal program lowered health care costs
stat
Jun 1, 26
The hidden history of BPC-157, a favorite MAHA peptide
stat
May 31, 26
#ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer study
endpoints
May 19, 26
Trump’s cuts to foreign aid are undermining the Ebola response, insiders say
stat
← prev
page 5 of 7
next →
